Brooke McCormick

1 day ago | ajmc.com | Brooke McCormick

Higher dietary inflammatory index (DII) scores are significantly associated with an increased risk of Alzheimer disease–related death among American adults, according to a study published in Experimental Gerontology.1 Although the exact mechanisms of Alzheimer disease remain unknown, accumulating evidence suggests that chronic inflammation plays a key role in its pathogenesis and progression.2 In particular, past research shows that neuroinflammation accelerates neuronal damage, synaptic...

2 days ago | ajmc.com | Brooke McCormick

Respiratory syncytial virus (RSV)–associated hospitalization rates were significantly lower among infants aged 0 to 7 months during the 2024-2025 RSV season, the first with widespread availability of prevention products, compared with pre–COVID-19 pandemic seasons, according to a recent study in the CDC’s Morbidity and Mortality Weekly Report.1 RSV remains the leading cause of hospitalization among US infants, with those aged 0 to 2 months at the highest risk.2 The researchers highlighted...

3 days ago | ajmc.com | Brooke McCormick

The real-world benefit of adding bevacizumab to a first-line chemotherapy regimen for patients with epithelial ovarian cancer was limited to those with high-risk prognostic factors, according to a study published Monday in Cancer.1 In the phase 3 GOG-0218 trial (NCT00262847), adding bevacizumab to first-line chemotherapy followed by bevacizumab maintenance therapy significantly prolonged progression-free survival (PFS) in patients with newly diagnosed, incompletely resected stage 3 or 4...

3 days ago | businessandamerica.com | Brooke McCormick

On this episode of Managed Care Cast, The American Journal of Managed Care® speaks with Larragem Raines, MS, director of research at the Center for Innovation & Value Research, about her organization’s open-source value model for major depressive disorder (MDD). She also defines dynamic pricing and explains how it is incorporated into the MDD value model, topics she expands upon in a recent contributor article.

5 days ago | businessandamerica.com | Brooke McCormick

In the final interview clip with Raymond Osarogiagbon, MD, director of the multidisciplinary thoracic oncology program at Baptist Cancer Center, recorded at the American Association for Cancer Research Annual Meeting 2025, he highlights promising innovations designed to boost lung cancer screening uptake. Watch parts 1, 2, and 3 to explore current US lung cancer screening guidelines, the consequences of low screening rates, and strategies to drive improvement.